ArticleMolecular therapy. Methods & clinical development2025

Optimization of hypo-alloimmunogenic multispecific CAR-T and SARS-CoV-2-specific T cells for off-the-shelf adoptive cell therapy.

King Pan Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.